Open AccessCombined Urinary Excretion of IgG and α2-Macroglobulina Very Simple Marker to Assess Disease Severity, Outcome Prediction and Responsiveness to Steroids and Cyclophosphamide in Patients with Chronic Glomerulonephritis and Nephrotic Syndrome
Author(s) -
Claudio Bazzi
Publication year - 2021
Publication title -
nephrology and renal therapy
Language(s) - English
Resource type - Journals
ISSN - 2473-7313
DOI - 10.24966/nrt-7313/100055
Subject(s) - nephrotic syndrome , cyclophosphamide , glomerulonephritis , medicine , disease , urinary system , minimal change disease , immunology , gastroenterology , chemotherapy , focal segmental glomerulosclerosis , kidney
In Glomerulonephritis (GN) with Nephrotic Syndrome (NS) proteinuric and molecular biomarkers don’t reach 100% of outcome prediction and treatment responsiveness.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom